Parenteral Drugs Industry Research Report 2025
Description
Summary
According to APO Research, the global Parenteral Drugs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Parenteral Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Parenteral Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Parenteral Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Parenteral Drugs include Albert David, Aspen Holdings, AXA Parenterals Ltd, BAG Healthcare, Baxter Healthcare Corporation, Beximco Pharma, BML Parenteral Drugs, Cook Pharmica and Ostuka Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Parenteral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Drugs.
The report will help the Parenteral Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Parenteral Drugs market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parenteral Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Parenteral Drugs Segment by Company
Albert David Aspen Holdings AXA Parenterals Ltd BAG Healthcare Baxter Healthcare Corporation Beximco Pharma BML Parenteral Drugs Cook Pharmica Ostuka Pharmaceutical Ozon Pharmaceuticals Ltd Patheon PSI Ltd Southwest Pharmaceutical B. Braun Cisen Fresenius Pfizer (Hospira) Kelun Pharma Acebright SSY Group Teva Pharmaceutical Industries AbbottParenteral Drugs Segment by Type
LVP Drug SVP DrugParenteral Drugs Segment by Application
Hospitals Medical Centers OthersParenteral Drugs Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Russia Spain Netherlands Switzerland Sweden Poland Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Colombia Middle East & Africa Egypt South Africa Israel Türkiye GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Parenteral Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Parenteral Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Parenteral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Parenteral Drugs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Parenteral Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Parenteral Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Parenteral Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Parenteral Drugs include Albert David, Aspen Holdings, AXA Parenterals Ltd, BAG Healthcare, Baxter Healthcare Corporation, Beximco Pharma, BML Parenteral Drugs, Cook Pharmica and Ostuka Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Parenteral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Drugs.
The report will help the Parenteral Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Parenteral Drugs market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parenteral Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Parenteral Drugs Segment by Company
Albert David Aspen Holdings AXA Parenterals Ltd BAG Healthcare Baxter Healthcare Corporation Beximco Pharma BML Parenteral Drugs Cook Pharmica Ostuka Pharmaceutical Ozon Pharmaceuticals Ltd Patheon PSI Ltd Southwest Pharmaceutical B. Braun Cisen Fresenius Pfizer (Hospira) Kelun Pharma Acebright SSY Group Teva Pharmaceutical Industries AbbottParenteral Drugs Segment by Type
LVP Drug SVP DrugParenteral Drugs Segment by Application
Hospitals Medical Centers OthersParenteral Drugs Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Russia Spain Netherlands Switzerland Sweden Poland Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Colombia Middle East & Africa Egypt South Africa Israel Türkiye GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Parenteral Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Parenteral Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Parenteral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
148 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Parenteral Drugs Market Size (2020-2031)
- 2.2.2 Global Parenteral Drugs Sales (2020-2031)
- 2.2.3 Global Parenteral Drugs Market Average Price (2020-2031)
- 2.3 Parenteral Drugs by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 LVP Drug
- 2.3.3 SVP Drug
- 2.4 Parenteral Drugs by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Hospitals
- 2.4.3 Medical Centers
- 2.4.4 Others
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Parenteral Drugs Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Parenteral Drugs Sales (k units) of Manufacturers (2020-2025)
- 3.3 Global Parenteral Drugs Revenue of Manufacturers (2020-2025)
- 3.4 Global Parenteral Drugs Average Price by Manufacturers (2020-2025)
- 3.5 Global Parenteral Drugs Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Parenteral Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Parenteral Drugs, Product Type & Application
- 3.8 Global Manufacturers of Parenteral Drugs, Established Date
- 3.9 Global Parenteral Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Albert David
- 4.1.1 Albert David Company Information
- 4.1.2 Albert David Business Overview
- 4.1.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Albert David Parenteral Drugs Product Portfolio
- 4.1.5 Albert David Recent Developments
- 4.2 Aspen Holdings
- 4.2.1 Aspen Holdings Company Information
- 4.2.2 Aspen Holdings Business Overview
- 4.2.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Aspen Holdings Parenteral Drugs Product Portfolio
- 4.2.5 Aspen Holdings Recent Developments
- 4.3 AXA Parenterals Ltd
- 4.3.1 AXA Parenterals Ltd Company Information
- 4.3.2 AXA Parenterals Ltd Business Overview
- 4.3.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 AXA Parenterals Ltd Parenteral Drugs Product Portfolio
- 4.3.5 AXA Parenterals Ltd Recent Developments
- 4.4 BAG Healthcare
- 4.4.1 BAG Healthcare Company Information
- 4.4.2 BAG Healthcare Business Overview
- 4.4.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 BAG Healthcare Parenteral Drugs Product Portfolio
- 4.4.5 BAG Healthcare Recent Developments
- 4.5 Baxter Healthcare Corporation
- 4.5.1 Baxter Healthcare Corporation Company Information
- 4.5.2 Baxter Healthcare Corporation Business Overview
- 4.5.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Baxter Healthcare Corporation Parenteral Drugs Product Portfolio
- 4.5.5 Baxter Healthcare Corporation Recent Developments
- 4.6 Beximco Pharma
- 4.6.1 Beximco Pharma Company Information
- 4.6.2 Beximco Pharma Business Overview
- 4.6.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Beximco Pharma Parenteral Drugs Product Portfolio
- 4.6.5 Beximco Pharma Recent Developments
- 4.7 BML Parenteral Drugs
- 4.7.1 BML Parenteral Drugs Company Information
- 4.7.2 BML Parenteral Drugs Business Overview
- 4.7.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 BML Parenteral Drugs Parenteral Drugs Product Portfolio
- 4.7.5 BML Parenteral Drugs Recent Developments
- 4.8 Cook Pharmica
- 4.8.1 Cook Pharmica Company Information
- 4.8.2 Cook Pharmica Business Overview
- 4.8.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Cook Pharmica Parenteral Drugs Product Portfolio
- 4.8.5 Cook Pharmica Recent Developments
- 4.9 Ostuka Pharmaceutical
- 4.9.1 Ostuka Pharmaceutical Company Information
- 4.9.2 Ostuka Pharmaceutical Business Overview
- 4.9.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 Ostuka Pharmaceutical Parenteral Drugs Product Portfolio
- 4.9.5 Ostuka Pharmaceutical Recent Developments
- 4.10 Ozon Pharmaceuticals Ltd
- 4.10.1 Ozon Pharmaceuticals Ltd Company Information
- 4.10.2 Ozon Pharmaceuticals Ltd Business Overview
- 4.10.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio
- 4.10.5 Ozon Pharmaceuticals Ltd Recent Developments
- 4.11 Patheon
- 4.11.1 Patheon Company Information
- 4.11.2 Patheon Business Overview
- 4.11.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.11.4 Patheon Parenteral Drugs Product Portfolio
- 4.11.5 Patheon Recent Developments
- 4.12 PSI Ltd
- 4.12.1 PSI Ltd Company Information
- 4.12.2 PSI Ltd Business Overview
- 4.12.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.12.4 PSI Ltd Parenteral Drugs Product Portfolio
- 4.12.5 PSI Ltd Recent Developments
- 4.13 Southwest Pharmaceutical
- 4.13.1 Southwest Pharmaceutical Company Information
- 4.13.2 Southwest Pharmaceutical Business Overview
- 4.13.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.13.4 Southwest Pharmaceutical Parenteral Drugs Product Portfolio
- 4.13.5 Southwest Pharmaceutical Recent Developments
- 4.14 B. Braun
- 4.14.1 B. Braun Company Information
- 4.14.2 B. Braun Business Overview
- 4.14.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.14.4 B. Braun Parenteral Drugs Product Portfolio
- 4.14.5 B. Braun Recent Developments
- 4.15 Cisen
- 4.15.1 Cisen Company Information
- 4.15.2 Cisen Business Overview
- 4.15.3 Cisen Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.15.4 Cisen Parenteral Drugs Product Portfolio
- 4.15.5 Cisen Recent Developments
- 4.16 Fresenius
- 4.16.1 Fresenius Company Information
- 4.16.2 Fresenius Business Overview
- 4.16.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.16.4 Fresenius Parenteral Drugs Product Portfolio
- 4.16.5 Fresenius Recent Developments
- 4.17 Pfizer (Hospira)
- 4.17.1 Pfizer (Hospira) Company Information
- 4.17.2 Pfizer (Hospira) Business Overview
- 4.17.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.17.4 Pfizer (Hospira) Parenteral Drugs Product Portfolio
- 4.17.5 Pfizer (Hospira) Recent Developments
- 4.18 Kelun Pharma
- 4.18.1 Kelun Pharma Company Information
- 4.18.2 Kelun Pharma Business Overview
- 4.18.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.18.4 Kelun Pharma Parenteral Drugs Product Portfolio
- 4.18.5 Kelun Pharma Recent Developments
- 4.19 Acebright
- 4.19.1 Acebright Company Information
- 4.19.2 Acebright Business Overview
- 4.19.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.19.4 Acebright Parenteral Drugs Product Portfolio
- 4.19.5 Acebright Recent Developments
- 4.20 SSY Group
- 4.20.1 SSY Group Company Information
- 4.20.2 SSY Group Business Overview
- 4.20.3 SSY Group Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.20.4 SSY Group Parenteral Drugs Product Portfolio
- 4.20.5 SSY Group Recent Developments
- 4.21 Teva Pharmaceutical Industries
- 4.21.1 Teva Pharmaceutical Industries Company Information
- 4.21.2 Teva Pharmaceutical Industries Business Overview
- 4.21.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.21.4 Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio
- 4.21.5 Teva Pharmaceutical Industries Recent Developments
- 4.22 Abbott
- 4.22.1 Abbott Company Information
- 4.22.2 Abbott Business Overview
- 4.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.22.4 Abbott Parenteral Drugs Product Portfolio
- 4.22.5 Abbott Recent Developments
- 5 Global Parenteral Drugs Market Scenario by Region
- 5.1 Global Parenteral Drugs Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Parenteral Drugs Sales by Region: 2020-2031
- 5.2.1 Global Parenteral Drugs Sales by Region: 2020-2025
- 5.2.2 Global Parenteral Drugs Sales by Region: 2026-2031
- 5.3 Global Parenteral Drugs Revenue by Region: 2020-2031
- 5.3.1 Global Parenteral Drugs Revenue by Region: 2020-2025
- 5.3.2 Global Parenteral Drugs Revenue by Region: 2026-2031
- 5.4 North America Parenteral Drugs Market Facts & Figures by Country
- 5.4.1 North America Parenteral Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Parenteral Drugs Sales by Country (2020-2031)
- 5.4.3 North America Parenteral Drugs Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Parenteral Drugs Market Facts & Figures by Country
- 5.5.1 Europe Parenteral Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Parenteral Drugs Sales by Country (2020-2031)
- 5.5.3 Europe Parenteral Drugs Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Parenteral Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Parenteral Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Parenteral Drugs Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Parenteral Drugs Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Parenteral Drugs Market Facts & Figures by Country
- 5.7.1 South America Parenteral Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Parenteral Drugs Sales by Country (2020-2031)
- 5.7.3 South America Parenteral Drugs Revenue by Country (2020-2031)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Parenteral Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Parenteral Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Parenteral Drugs Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Parenteral Drugs Revenue by Country (2020-2031)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
- 6 Segment by Type
- 6.1 Global Parenteral Drugs Sales by Type (2020-2031)
- 6.1.1 Global Parenteral Drugs Sales by Type (2020-2031) & (k units)
- 6.1.2 Global Parenteral Drugs Sales Market Share by Type (2020-2031)
- 6.2 Global Parenteral Drugs Revenue by Type (2020-2031)
- 6.2.1 Global Parenteral Drugs Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Parenteral Drugs Revenue Market Share by Type (2020-2031)
- 6.3 Global Parenteral Drugs Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Parenteral Drugs Sales by Application (2020-2031)
- 7.1.1 Global Parenteral Drugs Sales by Application (2020-2031) & (k units)
- 7.1.2 Global Parenteral Drugs Sales Market Share by Application (2020-2031)
- 7.2 Global Parenteral Drugs Revenue by Application (2020-2031)
- 7.2.1 Global Parenteral Drugs Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Parenteral Drugs Revenue Market Share by Application (2020-2031)
- 7.3 Global Parenteral Drugs Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Parenteral Drugs Value Chain Analysis
- 8.1.1 Parenteral Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Parenteral Drugs Production Mode & Process
- 8.2 Parenteral Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Parenteral Drugs Distributors
- 8.2.3 Parenteral Drugs Customers
- 9 Global Parenteral Drugs Analyzing Market Dynamics
- 9.1 Parenteral Drugs Industry Trends
- 9.2 Parenteral Drugs Industry Drivers
- 9.3 Parenteral Drugs Industry Opportunities and Challenges
- 9.4 Parenteral Drugs Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Parenteral Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Parenteral Drugs Sales (k units) of Manufacturers (2020-2025)
- Table 7. Global Parenteral Drugs Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Parenteral Drugs Revenue of Manufacturers (2020-2025)
- Table 9. Global Parenteral Drugs Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Parenteral Drugs Average Price (US$/unit) of Manufacturers (2020-2025)
- Table 11. Global Parenteral Drugs Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Parenteral Drugs, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Parenteral Drugs, Product Type & Application
- Table 14. Global Parenteral Drugs Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Parenteral Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Albert David Company Information
- Table 19. Albert David Business Overview
- Table 20. Albert David Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 21. Albert David Parenteral Drugs Product Portfolio
- Table 22. Albert David Recent Developments
- Table 23. Aspen Holdings Company Information
- Table 24. Aspen Holdings Business Overview
- Table 25. Aspen Holdings Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 26. Aspen Holdings Parenteral Drugs Product Portfolio
- Table 27. Aspen Holdings Recent Developments
- Table 28. AXA Parenterals Ltd Company Information
- Table 29. AXA Parenterals Ltd Business Overview
- Table 30. AXA Parenterals Ltd Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 31. AXA Parenterals Ltd Parenteral Drugs Product Portfolio
- Table 32. AXA Parenterals Ltd Recent Developments
- Table 33. BAG Healthcare Company Information
- Table 34. BAG Healthcare Business Overview
- Table 35. BAG Healthcare Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 36. BAG Healthcare Parenteral Drugs Product Portfolio
- Table 37. BAG Healthcare Recent Developments
- Table 38. Baxter Healthcare Corporation Company Information
- Table 39. Baxter Healthcare Corporation Business Overview
- Table 40. Baxter Healthcare Corporation Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 41. Baxter Healthcare Corporation Parenteral Drugs Product Portfolio
- Table 42. Baxter Healthcare Corporation Recent Developments
- Table 43. Beximco Pharma Company Information
- Table 44. Beximco Pharma Business Overview
- Table 45. Beximco Pharma Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 46. Beximco Pharma Parenteral Drugs Product Portfolio
- Table 47. Beximco Pharma Recent Developments
- Table 48. BML Parenteral Drugs Company Information
- Table 49. BML Parenteral Drugs Business Overview
- Table 50. BML Parenteral Drugs Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 51. BML Parenteral Drugs Parenteral Drugs Product Portfolio
- Table 52. BML Parenteral Drugs Recent Developments
- Table 53. Cook Pharmica Company Information
- Table 54. Cook Pharmica Business Overview
- Table 55. Cook Pharmica Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 56. Cook Pharmica Parenteral Drugs Product Portfolio
- Table 57. Cook Pharmica Recent Developments
- Table 58. Ostuka Pharmaceutical Company Information
- Table 59. Ostuka Pharmaceutical Business Overview
- Table 60. Ostuka Pharmaceutical Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 61. Ostuka Pharmaceutical Parenteral Drugs Product Portfolio
- Table 62. Ostuka Pharmaceutical Recent Developments
- Table 63. Ozon Pharmaceuticals Ltd Company Information
- Table 64. Ozon Pharmaceuticals Ltd Business Overview
- Table 65. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 66. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio
- Table 67. Ozon Pharmaceuticals Ltd Recent Developments
- Table 68. Patheon Company Information
- Table 69. Patheon Business Overview
- Table 70. Patheon Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 71. Patheon Parenteral Drugs Product Portfolio
- Table 72. Patheon Recent Developments
- Table 73. PSI Ltd Company Information
- Table 74. PSI Ltd Business Overview
- Table 75. PSI Ltd Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 76. PSI Ltd Parenteral Drugs Product Portfolio
- Table 77. PSI Ltd Recent Developments
- Table 78. Southwest Pharmaceutical Company Information
- Table 79. Southwest Pharmaceutical Business Overview
- Table 80. Southwest Pharmaceutical Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 81. Southwest Pharmaceutical Parenteral Drugs Product Portfolio
- Table 82. Southwest Pharmaceutical Recent Developments
- Table 83. B. Braun Company Information
- Table 84. B. Braun Business Overview
- Table 85. B. Braun Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 86. B. Braun Parenteral Drugs Product Portfolio
- Table 87. B. Braun Recent Developments
- Table 88. Cisen Company Information
- Table 89. Cisen Business Overview
- Table 90. Cisen Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 91. Cisen Parenteral Drugs Product Portfolio
- Table 92. Cisen Recent Developments
- Table 93. Fresenius Company Information
- Table 94. Fresenius Business Overview
- Table 95. Fresenius Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 96. Fresenius Parenteral Drugs Product Portfolio
- Table 97. Fresenius Recent Developments
- Table 98. Pfizer (Hospira) Company Information
- Table 99. Pfizer (Hospira) Business Overview
- Table 100. Pfizer (Hospira) Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 101. Pfizer (Hospira) Parenteral Drugs Product Portfolio
- Table 102. Pfizer (Hospira) Recent Developments
- Table 103. Kelun Pharma Company Information
- Table 104. Kelun Pharma Business Overview
- Table 105. Kelun Pharma Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 106. Kelun Pharma Parenteral Drugs Product Portfolio
- Table 107. Kelun Pharma Recent Developments
- Table 108. Acebright Company Information
- Table 109. Acebright Business Overview
- Table 110. Acebright Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 111. Acebright Parenteral Drugs Product Portfolio
- Table 112. Acebright Recent Developments
- Table 113. SSY Group Company Information
- Table 114. SSY Group Business Overview
- Table 115. SSY Group Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 116. SSY Group Parenteral Drugs Product Portfolio
- Table 117. SSY Group Recent Developments
- Table 118. Teva Pharmaceutical Industries Company Information
- Table 119. Teva Pharmaceutical Industries Business Overview
- Table 120. Teva Pharmaceutical Industries Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 121. Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio
- Table 122. Teva Pharmaceutical Industries Recent Developments
- Table 123. Abbott Company Information
- Table 124. Abbott Business Overview
- Table 125. Abbott Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 126. Abbott Parenteral Drugs Product Portfolio
- Table 127. Abbott Recent Developments
- Table 128. Global Parenteral Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 129. Global Parenteral Drugs Sales by Region (2020-2025) & (k units)
- Table 130. Global Parenteral Drugs Sales Market Share by Region (2020-2025)
- Table 131. Global Parenteral Drugs Sales by Region (2026-2031) & (k units)
- Table 132. Global Parenteral Drugs Sales Market Share by Region (2026-2031)
- Table 133. Global Parenteral Drugs Revenue by Region (2020-2025) & (US$ Million)
- Table 134. Global Parenteral Drugs Revenue Market Share by Region (2020-2025)
- Table 135. Global Parenteral Drugs Revenue by Region (2026-2031) & (US$ Million)
- Table 136. Global Parenteral Drugs Revenue Market Share by Region (2026-2031)
- Table 137. North America Parenteral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 138. North America Parenteral Drugs Sales by Country (2020-2025) & (k units)
- Table 139. North America Parenteral Drugs Sales by Country (2026-2031) & (k units)
- Table 140. North America Parenteral Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 141. North America Parenteral Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 142. Europe Parenteral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 143. Europe Parenteral Drugs Sales by Country (2020-2025) & (k units)
- Table 144. Europe Parenteral Drugs Sales by Country (2026-2031) & (k units)
- Table 145. Europe Parenteral Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 146. Europe Parenteral Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 147. Asia Pacific Parenteral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 148. Asia Pacific Parenteral Drugs Sales by Country (2020-2025) & (k units)
- Table 149. Asia Pacific Parenteral Drugs Sales by Country (2026-2031) & (k units)
- Table 150. Asia Pacific Parenteral Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 151. Asia Pacific Parenteral Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 152. South America Parenteral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 153. South America Parenteral Drugs Sales by Country (2020-2025) & (k units)
- Table 154. South America Parenteral Drugs Sales by Country (2026-2031) & (k units)
- Table 155. South America Parenteral Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 156. South America Parenteral Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 157. Middle East and Africa Parenteral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 158. Middle East and Africa Parenteral Drugs Sales by Country (2020-2025) & (k units)
- Table 159. Middle East and Africa Parenteral Drugs Sales by Country (2026-2031) & (k units)
- Table 160. Middle East and Africa Parenteral Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 161. Middle East and Africa Parenteral Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 162. Global Parenteral Drugs Sales by Type (2020-2025) & (k units)
- Table 163. Global Parenteral Drugs Sales by Type (2026-2031) & (k units)
- Table 164. Global Parenteral Drugs Sales Market Share by Type (2020-2025)
- Table 165. Global Parenteral Drugs Sales Market Share by Type (2026-2031)
- Table 166. Global Parenteral Drugs Revenue by Type (2020-2025) & (US$ Million)
- Table 167. Global Parenteral Drugs Revenue by Type (2026-2031) & (US$ Million)
- Table 168. Global Parenteral Drugs Revenue Market Share by Type (2020-2025)
- Table 169. Global Parenteral Drugs Revenue Market Share by Type (2026-2031)
- Table 170. Global Parenteral Drugs Price by Type (2020-2025) & (US$/unit)
- Table 171. Global Parenteral Drugs Price by Type (2026-2031) & (US$/unit)
- Table 172. Global Parenteral Drugs Sales by Application (2020-2025) & (k units)
- Table 173. Global Parenteral Drugs Sales by Application (2026-2031) & (k units)
- Table 174. Global Parenteral Drugs Sales Market Share by Application (2020-2025)
- Table 175. Global Parenteral Drugs Sales Market Share by Application (2026-2031)
- Table 176. Global Parenteral Drugs Revenue by Application (2020-2025) & (US$ Million)
- Table 177. Global Parenteral Drugs Revenue by Application (2026-2031) & (US$ Million)
- Table 178. Global Parenteral Drugs Revenue Market Share by Application (2020-2025)
- Table 179. Global Parenteral Drugs Revenue Market Share by Application (2026-2031)
- Table 180. Global Parenteral Drugs Price by Application (2020-2025) & (US$/unit)
- Table 181. Global Parenteral Drugs Price by Application (2026-2031) & (US$/unit)
- Table 182. Key Raw Materials
- Table 183. Raw Materials Key Suppliers
- Table 184. Parenteral Drugs Distributors List
- Table 185. Parenteral Drugs Customers List
- Table 186. Parenteral Drugs Industry Trends
- Table 187. Parenteral Drugs Industry Drivers
- Table 188. Parenteral Drugs Industry Restraints
- Table 189. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Parenteral Drugs Product Image
- Figure 5. Global Parenteral Drugs Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Parenteral Drugs Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Parenteral Drugs Sales (2020-2031) & (k units)
- Figure 8. Global Parenteral Drugs Average Price (US$/unit) & (2020-2031)
- Figure 9. LVP Drug Product Image
- Figure 10. SVP Drug Product Image
- Figure 11. Hospitals Product Image
- Figure 12. Medical Centers Product Image
- Figure 13. Others Product Image
- Figure 14. Global Parenteral Drugs Revenue Share by Manufacturers in 2024
- Figure 15. Global Manufacturers of Parenteral Drugs, Manufacturing Sites & Headquarters
- Figure 16. Global Top 5 and 10 Parenteral Drugs Players Market Share by Revenue in 2024
- Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 18. Global Parenteral Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 19. Global Parenteral Drugs Sales by Region in 2024
- Figure 20. Global Parenteral Drugs Revenue by Region in 2024
- Figure 21. North America Parenteral Drugs Market Size by Country in 2024
- Figure 22. North America Parenteral Drugs Sales Market Share by Country (2020-2031)
- Figure 23. North America Parenteral Drugs Revenue Market Share by Country (2020-2031)
- Figure 24. United States Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 25. Canada Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 26. Mexico Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 27. Europe Parenteral Drugs Market Size by Country in 2024
- Figure 28. Europe Parenteral Drugs Sales Market Share by Country (2020-2031)
- Figure 29. Europe Parenteral Drugs Revenue Market Share by Country (2020-2031)
- Figure 30. Germany Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 31. France Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 32. U.K. Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. Italy Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. Russia Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 35. Spain Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 36. Netherlands Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Switzerland Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 38. Sweden Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 39. Poland Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 40. Asia Pacific Parenteral Drugs Market Size by Country in 2024
- Figure 41. Asia Pacific Parenteral Drugs Sales Market Share by Country (2020-2031)
- Figure 42. Asia Pacific Parenteral Drugs Revenue Market Share by Country (2020-2031)
- Figure 43. China Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 44. Japan Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 45. South Korea Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 46. India Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 47. Australia Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. Taiwan Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 49. Southeast Asia Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 50. Southeast Asia Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 51. South America Parenteral Drugs Market Size by Country in 2024
- Figure 52. Sout
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
